Catalent
CTLT
#1511
Rank
A$18.47 B
Marketcap
$101.77
Share price
0.00%
Change (1 day)
25.51%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2023 (TTM): -$1.94

According to Catalent's latest financial reports the company's current EPS (TTM) is -$2.07. In 2022 the company made an earnings per share (EPS) of $3.64 a decrease over its 2021 EPS that were of $5.24.

EPS history for Catalent from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.94-153.3%
2022$3.64-30.58%
2021$5.2479.67%
2020$2.92114.12%
2019$1.36-15%
2018$1.6075.44%
2017$0.91-22.97%
2016$1.19-59.56%
2015$2.93282.05%
2014$0.77-378.2%
2013-$0.28

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$1.27-161.24%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.20-41.86%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.26 9.30%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$10.24-595.35%๐Ÿ‡บ๐Ÿ‡ธ USA